Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome Academic Article uri icon

Overview

MeSH Major

  • Piperidines
  • Prader-Willi Syndrome
  • Pyrazoles

abstract

  • Rimonabant administration may be efficacious for weight loss in adults with PWS; unfortunately it is associated with an unacceptably high risk of psychiatric side effects. Future CB1 antagonists will need a better psychiatric profile before considered in the treatment of obesity in this genetic condition.

publication date

  • January 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3038245

Digital Object Identifier (DOI)

  • 10.1016/j.ejmg.2010.09.015

PubMed ID

  • 20965292

Additional Document Info

start page

  • 14

end page

  • 8

volume

  • 54

number

  • 1